Clinical Efficacy and Safety of Arbekacin against Pneumonia in Febrile Neutropenia: A Retrospective Study in Patients with Hematologic Malignancies

BACKGROUND: Arbekacin (ABK) is an aminoglycoside that exhibits anti-methicillin-resistant Staphylococcus aureus (MRSA) and anti-Pseudomonas aeruginosa activities. Therefore, for patients with febrile neutropenia (FN) and concurrent pneumonia suspected to be caused by MRSA, ABK may be sufficiently ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohashi, Takashi, Fujita, Yukiyoshi, Irisawa, Hiroyuki, Nakaminami, Hidemasa, Arai, Takahiro, Takahashi, Masumi, Momiyama, Emi, Murata, Naoya, Murayama, Kayoko, Saito, Taeko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987186/
https://www.ncbi.nlm.nih.gov/pubmed/35384420
http://dx.doi.org/10.3947/ic.2021.0126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987186/
https://www.ncbi.nlm.nih.gov/pubmed/35384420
http://dx.doi.org/10.3947/ic.2021.0126

Ejemplares similares